This fund is currently closed to new and renewal applications due to lack of sufficient funding. CPR allocates funding to all patient’s that are approved for a grant so that it is available when needed by the patient. Therefore, during the period that a fund is closed to new applications, CPR continues to provide support to all patients in those funds that have an active award. Funds reopen often so please continue to visit our Disease Fund page to check the status of the fund.Fund Type
Co-pay, Co-Insurance & DeductibleMaximum Award Level
$3,500 Per Year
- Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements All Insurance Types
- Must reside and receive treatment in the United States.
About Uterine Cancers
There are many types of uterine cancer and this fund covers any cancer occurring in the uterus. There are two main groups of uterine cancer:
Endometrial cancer – cancer that begins in cells lining the uterus. When cancer forms in the lining or mucus-secreting glands of the uterus, it is referred to as endometrial cancer. The majority of cancers of the uterus are endometrial cancers. Endometrial cancers may include but are not limited to the following types and alternative names: endometrial carcinoma, endometrial adenocarcinomas, uterine carcinomas, uterine carcinosarcomas, uterine adenocarcinomas, epithelial malignant neoplasms or malignant mixed mesodermal tumors.
Uterine sarcoma – cancer that begins in muscle or other tissues in the uterus. Uterine sarcoma forms in the muscle, connective tissue or supportive tissues of the uterus.
Types of uterine sarcoma are:
Uterine leiomyosarcoma – cancer that affects smooth muscle tissue. These tumors are most common in the abdomen, but can occur anywhere in the body, including the uterus.
Endometrial stromal sarcoma – starts in the connective tissue that supports the endometrium (endometrial stroma). Additional uterine sarcomas may include but are not limited to the following types and alternative names: carcinosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma, adenosarcoma, adenosarcoma with sarcomatous overgrowth, perivascular endothelial cell tumor (PEComa), mesenchymal tumors, undifferentiated endometrial sarcomas, smooth muscle tumors of uncertain malignant potential; Müllerian adenosarcomas, carcinofibromas, adenofibromas, and adenomyomas, uterine carcinosarcoma, mixed mesodermal tumor, uterine papillary serous carcinoma, and clear cell carcinoma.
- Foundation for Women’s Cancer1-312-578-1439
- American Cancer Society1-800-227-2345
- National Cancer Institute1-800-422-6237
- The American College of Obstetricians and Gynecologists
- Good Days877-968-7233
- Healthwell Foundation800-675-8416
- Leukemia & Lymphoma Society800-955-4572
- National Organization for Rare Disorders800-999-6673
- Needy Meds800-503-6897
- Patient Access Network Foundation866-316-7263
- Patient Services Inc.800-366-7741
- The Assistance Fund855-845-3663